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Abstract
Background: A diet where fat is mainly eaten in the morning and carbohydrates mainly in the evening (compared to the reverse order) was recently shown to worsen glycemic control in people with prediabetes.  
Objective: We investigated effects of the same dietary patterns on energy metabolism and daily profiles of circulating lipids, adipokines and inflammatory markers.
Design: In a randomized controlled cross-over trial, 29 non-obese men (with normal glucose tolerance, n=18; or impaired fasting glucose/glucose tolerance, n=11) underwent two isocaloric 4-week diets: (1) carbohydrate-rich meals until 13.30 and fat-rich meals between 16.30 and 22.00 (HC/HF) versus (2) inverse sequence of meals (HF/HC). During a 12h clinical investigation day (CID) after each intervention period, two meal tolerance tests were performed, at 09.00 and 15.40, respectively, according to the previous intervention. Substrate oxidation and concentrations of circulating lipids, adipokines and cytokines were assessed pre- and postprandially. Postprandial inflammatory response in leukocytes was analyzed ex vivo.
Results: Fasting carbohydrate oxidation decreased (p=0.004) and lipid oxidation increased (p=0.012) after the HC/HF diet. Fasting concentrations of blood markers did not differ between diets. The diets modulated daily profiles of carbohydrate oxidation, lipid oxidation and beta-hydroxybutyrate, while the average daily levels of these parameters showed no difference between the diets and no interaction between diet and glucose tolerance status. Diurnal patterns of triglycerides, LDL cholesterol, leptin, visfatin and of the LPS-induced cytokine secretion in blood leukocytes were also modulated by the diets. Average daily concentrations of leptin (p=0.017) and visfatin (p=0.041) were lower on the HF/HC diet compared to the HC/HF diet.
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Introduction
Obesity, type 2 diabetes and other obesity-associated diseases are a global health problem. The traditional therapeutic strategy for obesity treatment focussing on the quantity and quality of the meal ingested does not often lead to significant success,  ADDIN EN.CITE () thereby increasing the need for novel dietary approaches.
Timing of food intake, as becoming increasingly evident, is an important factor influencing energy/metabolic homeostasis and the risk of obesity (). Restricting the food availability to the light phase in mice (i.e. the rest phase in nocturnal animals) fed a high-fat diet increases weight gain (), whereas restricting the caloric intake to the dark phase (i.e. active phase in nocturnal animals) is protective against obesity, glucose intolerance, leptin resistance and other metabolic disturbances  ADDIN EN.CITE (). In humans, shift work and chronical jet lag – both conditions where individuals eat their meals at the “wrong” time of day, i.e. when they usually sleep – increase the risk of obesity, type 2 diabetes and cardiovascular diseases (). Interestingly, timing of the main meal in humans affects the effectivity of weight loss: “late eaters” lose less weight than “early eaters”  ADDIN EN.CITE (). The importance of meal timing for metabolic homeostasis suggests a pivotal role of circadian rhythms in metabolism (). 
Moreover, novel studies suggest that certain time windows are more suitable for the consumption of high-carb or high-fat food to maintain metabolic health. Particularly, Bray et al. showed that mice fed a high-fat diet during the end of the active phase (which corresponds to the evening in humans) had increased body weight, glucose intolerance, hyperinsulinemia, hypertriglyceridemia, and hyperleptinemia, compared with mice fed the same high-fat diet at the beginning of the active phase  ADDIN EN.CITE (). In agreement with this finding, epidemiological studies in humans showed that a carbohydrate-rich diet at the beginning of the day is protective against diabetes  ADDIN EN.CITE () and metabolic syndrome  ADDIN EN.CITE (). In contrast, dietary intervention studies showed that eating carbohydrates mostly at dinner within a hypocaloric diet led to more pronounced weight loss and improved glucose metabolism, blood lipids and inflammatory status in obese subjects  ADDIN EN.CITE (). Thus, data about metabolic effects of timed fat and carbohydrate intake in humans remain controversial and require further investigation.
We recently showed that a diet where fat is mainly eaten in the morning and carbohydrates mainly in the evening (compared to the reverse order) worsens glycemic control in people with prediabetes (). Based on the previous reports in rodents and men  ADDIN EN.CITE (, , , ), we here hypothesized that diurnal distribution of carbohydrates and fat also affected daily profiles of substrate oxidation, circulating lipids, adipokines and inflammatory markers in humans. 
Subjects and Methods
Study population
Details of the recruitment process, the inclusion and exclusion criteria as well as the screening examination were published recently (). Briefly, metabolically healthy men (18-68 years old) were recruited from the Berlin-Brandenburg area, Germany, by means of personal interview, flyers and posters in public places and advertising through newspapers. Men with a body mass index (BMI) between 22 and 34.9 kg/m² as well as fasting venous glucose concentrations < 126 mg/dL and 2h glucose concentrations < 200 mg/dL on a 75-g oral glucose tolerance test were eligible for participation. Exclusion criteria were as follows: weight changes > 2 kg within past two months; current shift work or history of shift work; diseases or conditions that might influence the outcome of the study, in particular diseases that influence body weight regulation. 
Out of 58 screened men, 32 men started the trial. Three men dropped out in the course of the study so that 29 completed the whole trial and were taken for final analysis.

Ethics
The study protocol and informed consent document were approved by the Medical Ethics Committee of Charité University Medicine, Berlin, Germany (EA2/074/12) and were in accordance with the Helsinki Declaration of 1975. All subjects gave written informed consent. The study was registered at clinicaltrial.gov as NCT02487576. 

Primary and secondary outcomes
Primary outcomes of the study were dietary-induced changes in glucose metabolism (glucose, insulin, glucagon, and incretins) published previously () and in circulating lipids. Secondary outcomes were circulating adipokines, cytokines and inflammatory response in blood leukocytes.

Study design
In this randomized, controlled cross-over trial, two 4-week isocaloric dietary interventions were applied: (1) a carbohydrate-rich diet until 13.30 and a fat-rich diet between 16.30 and 22.00 (HC/HF) versus (2) a fat-rich diet until 13.30 and a carbohydrate-rich diet between 16.30 and 22.00 (HF/HC) (Figure 1A). The carbohydrate-rich diet consisted of 65 energy percent (EN%) carbohydrates (CHO), 20 EN% fat and 15 EN% protein; the fat-rich diet was composed of 35 EN% CHO, 50 EN% fat and 15 EN% protein. The dietary intervention periods were followed by a 12h clinical investigation day and separated by a 4-week washout phase. Randomization was done by an independent statistician who was blinded regarding the allocation groups as described previously ().

Dietary interventions
Food records prior to dietary interventions
Participants were asked to complete a weighed food record for five consecutive days prior to both dietary interventions, including at least one weekend day, to determine habitual macronutrient composition and energy intakes. Participants were instructed to weigh all food whenever possible and to supply information on brand names, cooking, processing and meal times. When weighing was not possible (e.g. when dining out) they were instructed to record the food in household measures (cups, glasses, teaspoon…). Food records were analyzed with PRODI 6.1 expert software (Nutriscience, Stuttgart, Germany) which is based on the German Nutrient Database (Bundeslebensmittelschlüssel version 3.02). 

Dietary plans and instructions for intervention periods
To ensure good compliance in this outpatient nutritional study, individual dietary plans were formulated for each participant meeting the macronutrient composition of both diets and considering the individual food preferences as obtained from the food records. As well as possible, dietary plans were controlled for the amount of saturated fatty acids (SFA), starch and fiber as well as glycemic index (GI). Dietary plans were isocaloric with the product of the individual resting metabolic rate (RMR) and the physical activity (PA) level. The PA level was assessed for each participant individually using an in-house questionnaire including questions about the estimated duration of sleeping, sitting, walking and regular sports activities per day. The obtained energy need was compared to the mean daily energy intake assessed from the first food record. In cases where the mean daily energy intake was higher than the energy need calculated as the product of RMR and PA, the energy need was adjusted. 
Calories of dietary interventions were evenly distributed between morning (breakfast + lunch) and evening (snack + dinner) leading to a daily macronutrient composition of 50 EN% CHO, 35 EN% fat (14 EN% SFA) and 15 EN% protein. Plans were given as 7-d rotating menus and, whenever possible, 3-5 alternative food items were provided containing the same amount of the major macronutrient as the plan´s original food item.
Participants were supposed to buy and prepare the foods listed in the dietary plans at home. To reduce the financial burden and ensure good compliance, participants were provided with five frozen ready meals (FROSTA Tiefkühlkost GmbH, Hamburg, Germany) per week if desired. These ready meals were the same for all participants. 
Participants were instructed to have eaten breakfast and lunch by 13.30; snack and dinner should be consumed between 16.30 and 22.00. Only water, tea and, if they were usual coffee consumers, coffee without milk or sugar were allowed between 13.30 and 16.30. Participants were asked to daily document their food selection, consumed amount and time of each meal. Further, they were instructed to record their weight daily and report any weight fluctuation of ≥ 700g on two consecutive days. If necessary, dietary plans were modified to meet participants´ energy requirements. 
During the run-in, intervention and washout periods, participants were asked to avoid alcohol, maintain their normal coffee consumption and follow their regular routine of wakefulness and sleep and PA levels. 

Analysis of participants´ compliance
Seven completed and returned dietary protocols from each intervention period were analyzed for each participant with PRODI 6.1 expert software (Nutriscience, Stuttgart, Germany) to assess participants´ compliance. 

Pre-intervention examination and Clinical Investigation Day
Before (pre-intervention examination) and after (clinical investigation day) each intervention period, participants reported to the outpatient study center at the German Institute of Human Nutrition (Potsdam, Germany) for a 2-h and 12-h examination, respectively. All examinations included appointments with the physician and nutritionist. 
At the pre-intervention examination, anthropometrical measurements and indirect calorimetry were performed after an overnight fast. Body fat mass was measured via BOD POD-Air displacement plethysmograph (CosMed, Fridolfing, Germany). Fasted blood samples were drawn from the forearm vein, centrifuged at 1800 g for 10 min 4 °C and stored at -80°C until analysis. 
In the course of the clinical investigation day, two meal tolerance tests (MTT) were performed at 09.00 and 15.40 according to the previous intervention period (Figure 1B). Test meals were either high in carbohydrates (MTT-HC), 835 kcal or high in fat (MTT-HF), 849 kcal. The MTT-HC consisted of 120 g wheat bread roll, 50 g white toast, 65 g strawberry jam, 12.5 g butter, 16.7 g cream cheese (Philadelphia®) and 110 g low-fat curd leading to a macronutrient composition of 64.8 EN% CHO, 20.3 EN% fat, 14.8 EN% protein. The MTT-HF was composed of 119 g wheat bread, 17 g butter, 50.1 g cream cheese (Philadelphia®), 19 g cheese (Babybel®) and 150 g high-fat curd leading to a macronutrient composition of 35.3 EN% CHO, 49.6 EN% fat, 15.1 EN% protein. 250 ml water was served with each meal (). Participants ingested the test meals within 15 min. Blood samples were taken before (-5 min) and 180 min after completion of each test meal, i.e. at four time points in total. 
Indirect calorimetry was performed before the first meal (fasted) and 155 min after completion of each meal for 20 min, i.e. at three time points in total, in a recumbent position using an indirect calorimeter canopy (CareFusion, Yorba Linda, USA). Concomitantly urine was collected to determine urine nitrogen concentrations. Energy expenditure (EE) [kcal/min] values were obtained according to the Weir equation (): (3.9 x VO2 + 1.1 x VCO2) x 1.44. Respiratory quotient (RQ) was assessed as a ratio between the volume of carbon dioxide (VCO2) and the volume of oxygen (VO2), i.e. VCO2/VO2. Carbohydrate and lipid oxidation rates were calculated as follows. Carbohydrate oxidation [g/min] = (4.55 x VCO2) – (3.21 x VO2); and lipid oxidation [g/min] = (1.67 x VO2) – (1.67 x VCO2). Similar results were obtained, when the nitrogen production was included in equations accordingly to Frayn et al. ().
Analyses of serum samples
Routine laboratory markers were measured using standard methods (ABX Pentra 400; HORIBA, ABX SAS, France). Commercial ELISA were used for measurement of serum adiponectin (BioVendor, Germany), leptin, interleukin 6 (IL-6), monocyte chemoattractant protein-1 (MCP-1) (all from BioTechne R&D Systems GmbH, Germany), and visfatin/NAMPT (Biomol, Germany). Nitrogen content of urine was determined by the isotope-ratio mass spectrometer using acetanilide as the working standard ().

Ex vivo whole blood assay
Heparinized whole blood taken 180 min after each MTT (at 12.15 p.m. and at 7.00 p.m.) was immediately diluted with RPMI 1640 medium (Invitrogen/Life Technology, Germany) in a 1:5 ratio and supplemented with 1% antibiotic antimycotic solution (Sigma, Germany). Blood culture (2 ml/well) was incubated in 6-well TPP plates (Germany) for 22 h supplemented with 500 ng/ml lipopolysaccharide (LPS, Lipopolysaccharides from Escherichia coli, O111:B4, Sigma, Germany) or with solvent (RPMI 1640 medium). After incubation, supernatants were spun to remove cellular components and frozen at -80° C. Cytokines were measured with ProcartaPlex Multiplex Immunoassays (eBioscience/ Thermo Fisher Scientific, Germany).

Sample size and power calculation. 
Power calculation was completed using the nQuery Advisor 6.0. For the paired parametric design and the sample size of 28 subjects, the current study provided 80% power to detect 5% difference between groups, if the effect size was 0.55. To allow discontinuation, 32 participants started the trial.
Calculations and statistical analysis
Statistical analyses were performed with SPSS v.20 (SPSS, Chicago, IL). To estimate the effects of the dietary interventions on anthropometrical and metabolic parameters, linear mixed-effect models were applied with treatment, period and residual effect as fixed factors and subjects as a random factor (). Because no effect of the period and no residual effect were observed for any measured variable, for following analyses data were pooled in HC/HF and HF/HC groups. 
Repeated measures ANOVA was used to assess effects of the diets, time of the day and diet*time interaction as well as of the diet*subgroup interaction. Average concentrations of assessed parameters during the 12h investigation day were calculated from the four time points of data collection for blood lipids and adipokines, and from three time points for parameters of energy metabolism. The response to a meal challenge was calculated as the delta change, by subtracting the preprandial from the postprandial concentration. For the comparison of two groups, paired Student´s t-test or Wilcoxon test were used depending on the distribution of data. P values < 0.05 were considered significant in all analyses except of linear mixed model analysis where P ≤ 0.06 was considered significant. All data are presented as means ± SEMs.
Results
Study participants and dietary compliance
29 men (age 45.9 ± 2.5 years, BMI 27.1 ± 0.8 kg/m2) with normal glucose tolerance (NGT, n=18) or impaired fasting glucose/glucose tolerance (IFG/IGT, n=8 / n=4) completed the trial (). Adherence to dietary plans was good, with similar compliances for the two diets. There was no difference in energy intake, macronutrient composition, amount of saturated fatty acids, fiber and starch as well as GI between the two diets (). Despite extensive dietary advice, body weight and BMI slightly declined after four weeks of both HC/HF and HF/HC diet (Table 1). 

Daily profiles of substrate oxidation in response to HC/HF versus HF/HC diet
Because energy metabolism is affected by both food composition  ADDIN EN.CITE () and the time of day (), we firstly investigated the effect of both diets on daily profiles of the whole-body lipid and carbohydrate oxidation rates, RQ and EE. These parameters were assessed in the fasting state (at 8.00) and 155 min (at 11.50 and 18.30) after completion of each test meal using indirect calorimetry (Figure 1B). 
Fasting levels of EE, RQ, and beta-hydroxybutyrate (used as a marker of hepatic lipid oxidation ()), showed no difference in effects of HC/HF and HF/HC diets (Table 1). Both lipid and carbohydrate oxidation rates showed a difference between diets (p=0.050 and p=0.060, respectively) (Table 1). Fasting carbohydrate oxidation decreased by 24.1 % (p=0.004) and lipid oxidation increased by 15.9 % (p=0.012) after the HC/HF diet, whereas no significant substrate oxidation changes was induced by the HF/HC diet (Table 1).
Postprandial levels of the whole-body substrate oxidation and beta-hydroxybutyrate were highly dependent on the composition of the test meal (pdiet*time<0.001) (Figure 1D-G). Consumption of MTT-HC led to higher postprandial RQ and whole-body carbohydrate oxidation rate (RQ: p=0.003 and p<0.001; carbohydrate oxidation: p=0.001 and p<0.001, in the morning and in the afternoon, respectively) and lower whole-body lipid oxidation and beta-hydroxybutyrate concentrations in comparison with MTT-HF (lipid oxidation: p=0.005 and p=0.001; beta-hydroxybutyrate: p=0.003 and p=0.004, in the morning and in the afternoon, respectively) (Figure 1D-G). No significant differences between morning and afternoon levels of RER, EE, substrate oxidation, and beta-hydroxybutyrate after the same test meal were found (Figure 1C-G). However, the meal-induced suppression of beta-hydroxybutyrate was more pronounced in the afternoon (for MTT-HC) suggesting a time of day dependence in the response to food intake (p=0.022) (Supplemental Figure 1A). 
Average daily levels of the whole-body substrate oxidation and beta-hydroxybutyrate assessed during the 12h investigation day showed no difference between diets and no significant interaction between diet and glucose tolerance status (Table 2). 

Daily profiles of blood lipids in response to HC/HF versus HF/HC diet
To understand in detail how timed fat and carbohydrate intake affected the metabolic state, we then assessed daily profiles of circulating lipids using samples collected before and after each MTT. No differences between the two diets were found in their effects on fasting triglyceride, total, HDL and LDL cholesterol concentrations (Table 1).
Postprandial triglyceride, HDL and LDL cholesterol concentrations showed a complex regulation by both meal composition and the time of day (pdiet*time<0.001, pdiet*time=0.057, and pdiet*time<0.001, respectively) (Figure 2). Consumption of MTT-HF led to higher postprandial triglyceride concentrations (p<0.001 both in the morning and in the afternoon) and lower LDL cholesterol concentrations (p<0.001 in the afternoon) compared with MTT-HC (Figure 2A, D). Meal-induced changes of triglycerides and LDL cholesterol decreased in the afternoon compared with the morning (p<0.001 for both triglycerides and LDL cholesterol for both MTT-HC and MTT-HF) (Supplemental Figure 1B-E). Further, total cholesterol showed a downward trend during the day (ptime<0.001) (Figure 2B). 
The average daily concentrations of blood lipids did not differ between the two diets and showed no significant interaction between diet and glucose tolerance status (Table 2). 

Daily profiles of adipokines and inflammation markers in response to HC/HF versus HF/HC diet
We then assessed dietary effects on daily profiles of circulating adipokines (leptin, visfatin, adiponectin) and inflammation markers (IL-6, MCP-1, CRP). Dietary effects on fasting concentrations of these parameters were not significantly different (Table 1). 
Daily profiles of these markers demonstrated no postprandial changes. Daily profiles of leptin showed a significant difference between the two diets (pdiet=0.017), and average daily concentrations of leptin were 11.9% lower on the HF/HC diet compared to the HC/HF diet (Figure 3A, Table 2). Daily profiles of visfatin were also different between the two diets (pdiet=0.041), and the average daily concentration of visfatin was 7.2% lower on the HF/HC diet compared to the HC/HF diet (Figure 3B, Table 2). Visfatin profiles were weakly determined by the MTT composition. Visfatin concentrations were slightly higher after MTT-HF in comparison with MTT-HC in the afternoon (p<0.001) (Figure 3B). Average daily concentrations of leptin and visfatin showed no significant interaction between diet and glucose tolerance status (Table 2). 
Adiponectin concentrations were slightly decreased in the afternoon (ptime=0.004), whereas IL-6 and MCP-1 demonstrated an upward trend throughout the day (ptime<0.001 and ptime=0.004, respectively) (Figure 3C-E). Average daily concentrations of adiponectin, IL-6, MCP-1, and CRP were not different between diets and showed no significant interaction between diet and glucose tolerance status (Table 2). 




To our knowledge, the present study is the first human study to investigate the long-term effects of a diurnal distribution of carbohydrates and fat on substrate oxidation, blood lipids, adipokines and inflammatory markers. The main finding of the study is that an intake of different meals (high-carb or high-fat) at different times of the day (in the morning or in the afternoon) modulates daily profiles of substrate oxidation, metabolic and inflammatory markers and shifts average daily concentrations of adipokine secretion. 
Indeed, in our study, fasting lipid oxidation increased, and carbohydrate oxidation decreased after consumption of the HC/HF diet, i.e. when fat-rich meals were consumed in the afternoon/evening. Consuming fat rich meals in the afternoon/evening may “reprogram” the human metabolism preparing it for further fat consumption the next morning. This finding is in line with work by others showing that in humans the effects of the evening meal persist overnight, influencing substrate metabolism the next morning  ADDIN EN.CITE (). However, carbohydrate and lipid oxidation rates demonstrated anticipated changes during the CID in accordance with meal composition, and their average daily levels remained unaffected by diets. This might be explained by the good metabolic flexibility of study participants, namely non-obese men without diabetes. Metabolic flexibility (which is defined as the capacity of the body to match fuel oxidation with fuel availability) was shown to be impaired in individuals with obesity and type 2 diabetes  ADDIN EN.CITE (). In contrast to our human data, in mice, diurnal distribution of carbohydrate and fat intake was shown to affect the level of substrate oxidation throughout the whole active phase (7). In mice fed a high fat diet at the end (and a carbohydrate-rich diet at the beginning) of the active phase, RER values remained elevated throughout the waking period, suggesting a loss of metabolic flexibility. On the reverse dietary pattern, mice remained metabolically flexible showing low RER values at the beginning and high RER values at the end of the active phase (7).
Our findings confirm the importance of meal timing and circadian rhythms in the regulation of human metabolism. Circadian rhythms are endogenous ~ 24 h rhythms in behavior and physiology which allow organisms to adapt to day-night cycles and resultant changes in temperature and food availability (). Particularly, substrate utilization and oxidation are subjected to circadian control  ADDIN EN.CITE (, , ). Key enzymes of lipid oxidation peak at the beginning, while genes regulating lipid synthesis peak at the end of the active phase both in mice and humans  ADDIN EN.CITE (, ). In consensus with previous studies  ADDIN EN.CITE (), our results confirm that the rate of substrate oxidation in humans is affected not only by meal composition, but also by meal timing. Particularly, we found that postprandial suppression of beta-hydroxybutyrate depends on the time of day which is in agreement with findings showing a regulation of beta-hydroxybutyrate by clock genes (). Recent studies also showed that delaying the intake of an identical meal led to reduced whole-body carbohydrate oxidation rates  ADDIN EN.CITE (, ) and decreased diet-induced thermogenesis  ADDIN EN.CITE ().
Further in our study, circulating concentrations and postprandial changes of blood lipids showed a complex regulation by both the meal composition and the time of day. We suppose that components of lipid homeostasis which are under circadian control contribute to the daytime-dependent variation of blood lipid profiles - including intestinal lipid transport, lipogenesis, lipolysis and lipid oxidation  ADDIN EN.CITE (, , ). 
In our study, adipokines also showed a daytime-dependent variation which confirms literature data about the circadian regulation of adipokine secretion  ADDIN EN.CITE (, ). An important finding of our study is that the average leptin concentration during the 12h investigation day was higher on the HC/HF diet compared to the HF/HC diet which is in agreement with abovementioned mouse study  ADDIN EN.CITE (). Hyperleptinemia and leptin resistance are typically associated with obesity () and adipose tissue inflammation (). Yet, leptin is a potent appetite suppressor (), but no dietary-induced changes in hunger and satiety scores were found in our study (). Interestingly, carbohydrate consumption has been suggested to regulate leptin secretion  ADDIN EN.CITE (, ), whereas insulin and glucose stimulate leptin production (). Thus, because of the pleiotropic role of leptin in metabolic regulation, the metabolic implication of its decrease on the HF/HC diet requires further investigation. 
Similar to leptin, the average visfatin concentration was lower on the HF/HC diet compared with the HC/HF diet. Visfatin, also known as a nicotinamide phosphoribosyltransferase (NAMPT), is involved in both intracellular and extracellular functions (). Intracellular NAMPT is an enzyme which catalyzes the rate‐limiting step in the NAD+ biosynthesis and influences a variety of metabolic and stress responses. Circadian oscillations of NAMPT expression (and of the NAD+ concentration) are dampened by a high fat diet in mice  ADDIN EN.CITE (). Extracellular NAMPT/visfatin can be detected in the human circulation, and a range of studies showed its increase in obesity, insulin resistance and type 2 diabetes (). Visfatin is a proinflammatory mediator and is supposed to contribute to adipose tissue inflammation  ADDIN EN.CITE (). Hence, the visfatin decrease on the HF/HC diet might be considered as metabolically beneficial and might contradict our previous data showing an unfavorable effect of the HF/HC diet on glycemic control (). On the other hand, adipocyte-specific Nampt knockout mice have multi-organ insulin resistance  ADDIN EN.CITE (), and overexpression of visfatin/Nampt improved whole-body insulin sensitivity in rats  ADDIN EN.CITE (). Thus, data on the metabolic effects of visfatin are controversial, and future studies are needed to elucidate the clinical implications of our results in more detail.
Finally, in our study, we demonstrated diurnal variation of inflammatory markers in humans. Both circulating IL-6 and MCP-1 and the LPS-induced inflammatory response in blood leukocytes were increased in the afternoon and additionally modulated by meal composition. Similarly, other studies also showed circadian regulation of immune response, immune cell number and functions such as cytokine expression, phagocytosis and lytic activity  ADDIN EN.CITE (, ).
Thus, in our study, we found that daily profiles of metabolic and inflammatory markers in humans are modulated by both the meal composition and meal timing. Many metabolic parameters such as plasma glucose, insulin, triglycerides etc. demonstrate endogenous clock-driven rhythms in constant feeding and lighting conditions (). Hence, daily patterns of metabolic markers represent endogenous circadian rhythms which are additionally modulated by external cues such as food intake and this finally results in a beneficial or detrimental metabolic outcome. Mechanisms of this regulation are very complex and include alterations in postprandial hormone and metabolite concentrations, hormone sensitivity, gastric emptying, substrate oxidation and utilization etc.  ADDIN EN.CITE (, ). Particularly, we and others showed that postprandial glucose and insulin were strikingly elevated in the afternoon compared to the morning concentrations, suggesting a decrease in glucose tolerance as the day progresses  ADDIN EN.CITE (, , ). 
In our study, we specifically chose to investigate dietary effects on the metabolic state in a real world setting to assess their clinical implications, and this is one of the strengths of the current study compared with constant routine protocol. Secondly, our study has the strength of being a randomized controlled trial with metabolically well-phenotyped participants, which is only possible in small-scale studies. Thirdly, the current study represents a long-term dietary intervention (i.e. four weeks), whereas previous reports on a diurnal carbohydrate and/or fat distribution described effects of short-term interventions.
In spite of using very carefully, thoughtfully designed dietary plans, some limitations need to be mentioned. Firstly, in some patients, we used an adjustment of energy need based on the food records. We used this adjustment only in cases where the mean daily energy intake was higher than the energy need calculated as the product of RMR and PA. However, this method may be problematic, particularly because of `underreporting` in dietary records, a common phenomenon in dietary studies (). It could be a reason why both diets led to a minor weight loss, which may have resulted in an improvement in metabolic parameters (without difference between diets). Another possible explanation of this phenomenon may be a reduction in snacking during the dietary intervention  ADDIN EN.CITE (). However, the cross-over design of this study should minimize any potential effect of the weight reduction.
Secondly, using individual dietary plans (which ensures good compliance) may have resulted in varying concentrations of macronutrients and bioactive compounds between our subjects. However, again, the cross-over design of our study should minimize any potential effect. Thirdly, our study was conducted in overweight, non-diabetic individuals and we cannot exclude that our diets would induce different metabolic effects in people with obesity and type 2 diabetes. 

In conclusion, the results of our study indicate that diurnal distribution of carbohydrates and fat affects daily profiles of substrate oxidation, circulating lipids and cytokine secretion and shifts average daily levels of adipokine secretion in humans. Our data suggest that both meal compositions and meal timing should be considered in the development of dietary strategies for the prevention and treatment of metabolic diseases.
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Table 1. Fasting parameters in response to the HC/HF and the HF/HC diet
	HC/HF diet	HF/HC diet	P1	Pcorr2
	Pre	Post	Δ%	Pre	Post	Δ%		
Weight [kg]	86.8 ± 2.8	86.4 ± 2.9	-0.5	87.1 ± 2.9	86.6 ± 2.9	-0.6	0.936	
BMI [kg/m²]	27.0 ± 0.7	26.8 ± 0.8	-0.7	27.1 ± 0.8	26.9 ± 0.8	-0.7	0.917	
Total body fat [%]	24.7 ± 1.5	24.2 ± 1.7	-2.0	24.5 ± 1.7	23.3 ± 1.7	-4.9	0.206	
Energy metabolism								
EE3 [kcal]	1715 ± 57	1681 ± 59	-2.0	1704 ± 50	1696 ± 52	-0.5	0.995	
RQ3 [VCO2/VO2]	0.83 ± 0.01	0.81 ± 0.01	-2.4	0.85 ± 0.01	0.80 ± 0.01	-5.9	0.502	
Carbohydrate oxidation3 [g/min]	0.158 ± 0.015	0.120 ± 0.012	-24.1**	0.149 ± 0.016	0.125 ± 0.009	-16.1	0.060	
Lipid oxidation3 [g/min]	0.069 ± 0.006	0.080 ± 0.004	15.9*	0.068 ± 0.005	0.073 ± 0.004	7.4	0.050	
Beta-hydroxybutyrate [mg/l]	10.7 ± 0.8	11.4 ± 0.7	6.5	12.2 ± 1.2	11.6 ± 1.2	-4.9	0.332	0.330
Lipid metabolism								
Triglycerides [mmol/l]	1.15 ± 0.13	1.07 ± 0.11	-7.0	1.25 ± 0.16	1.17 ± 0.11	-6.4	0.666	0.666
Total cholesterol [mmol/l]	5.22 ± 0.17	4.78 ± 0.16	-8.4	5.24 ± 0.18	4.88 ± 0.18	-6.9	0.347	0.273
HDL cholesterol [mmol/l]	1.24 ± 0.04	1.08 ± 0.03	-12.9	1.21 ± 0.04	1.08 ± 0.03	-10.7	0.737	0.704
LDL cholesterol [mmol/l]	3.46 ± 0.16	3.21 ± 0.15	-7.2	3.46 ± 0.17	3.27 ± 0.16	-5.5	0.571	0.527
Inflammation markers and adipokines
Leptin [pg/ml]	8308 ± 1424	7329 ± 1244	-11.8	8411 ± 1354	6800 ± 1068	-19.2	0.690	0.617
Visfatin [ng/ml]	1.12 ± 0.25	1.16 ± 0.23	3.8	0.93 ± 0.22	1.02 ± 0.22	10.2	0.419	0.423
Adiponectin [µg/ml]	7.93 ± 0.49	7.10 ± 0.41	-10.5	7.87 ± 0.43	7.01 ± 0.44	-10.9	0.715	0.722
IL-6 [pg/ml]	1.32 ± 0.18	1.16 ± 0.11	-12.1	1.10 ± 0.1	1.21 ± 0.1	10.0	0.132	0.117
MCP-1 [pg/ml]	369.3 ± 36.4	348.6 ± 39.6	-5.7	385.2 ± 45.2	349.4 ± 35.4	-9.4	0.673	0.679
CRP [mg/l]	1.13 ± 0.27	0.90 ± 0.19	-20.4	0.97 ± 0.25	0.80 ± 0.19	-17.5	0.922	0.928
Data are shown as mean ± SEM, n = 29 unless otherwise indicated. 
* – P-value for the difference from baseline, *p<0.05, ** p<0.01 (paired Student´s t-test or Wilcoxon test).
1 – P-value for the comparison of changes after HC/HF and HF/HC diets in the linear mixed model.
2 – P-value for the comparison of changes after HC/HF and HF/HC diets in the linear mixed model after correction for weight change.
3 – n=27.





Table 2. Average concentrations during the 12h investigation day in response to the HC/HF and HF/HC diet
	All subjects		NGT subjects		IFG/IGT subjects		P1
	HC/HF	HF/HC	Δ%	HC/HF	HF/HC	Δ%	HC/HF	HF/HC	Δ%	
Energy metabolism										
EE2 [kcal]	1813 ± 56	1825 ± 50	0.7	1807 ± 55	1796 ± 67	-0.6	1821 ± 118	1874 ± 75	2.9	0.216
RQ2 [VCO2/VO2]	0.855 ± 0.007	0.852 ± 0.007	-0.3	0.860 ± 0.009	0.865 ± 0.009	0.6	0.847 ± 0.012	0.833 ± 0.010	-1.7	0.161
Carbohydrate oxidation2 [g/min]	0.186 ± 0.010	0.183 ± 0.009	-1.9	0.191 ± 0.011	0.188 ± 0.010	-1.5	0.178 ± 0.022	0.171 ± 0.019	-3.9	0.477
Lipid oxidation2 [g/min]	0.064 ± 0.004	0.061 ± 0.003	-5.1	0.061 ± 0.004	0.055 ± 0.003	-10.1	0.068 ± 0.006	0.072 ± 0.005	5.0	0.269
Beta-hydroxybutyrate [mg/l]	8.82 ± 0.54	9.70 ± 0.66	10.0	8.87 ± 0.72	9.97 ± 0.84	12.4	8.73 ± 0.85	9.21 ± 1.12	5.5	0.551
Lipid metabolism										
Triglycerides [mmol/l]	1.46 ± 0.14	1.48 ± 0.13	2.0	1.35 ± 0.13	1.40 ± 0.11	3.6	1.62 ± 0.31	1.62 ± 0.28	-0.1	0.824
Total cholesterol [mmol/l]	4.56 ± 0.14	4.67 ± 0.15	2.4	4.51 ± 0.16	4.67 ± 0.19	3.6	4.63 ± 0.29	4.67 ± 0.27	0.7	0.387
HDL cholesterol [mmol/l]	1.04 ± 0.03	1.05 ± 0.03	1.5	1.06 ± 0.05	1.10 ± 0.04	3.5	1.00 ± 0.04	0.98 ± 0.04	-2.0	0.135
LDL cholesterol [mmol/l]	2.86 ± 0.13	2.94 ± 0.15	2.9	2.83 ± 0.14	2.93 ± 0.19	3.6	2.90 ± 0.27	2.95 ± 0.23	1.8	0.709
Inflammation markers and adipokines								
Leptin [pg/ml]	7982 ± 1290	7035 ± 1087	-11.9*	8417 ± 1954	7121 ± 1597	-15.4	7269 ± 1256	6895 ± 1272	-5.2	0.304
Visfatin [ng/ml]	1.11 ± 0.22	1.03 ± 0.26	-7.2*	1.34 ± 0.33	1.27 ± 0.41	-5.1	0.76 ± 0.16	0.66 ± 0.13	-13.1	0.977
Adiponectin [ug/ml]	7.00 ± 0.43	7.01 ± 0.42	0.1	7.40 ± 0.60	7.61 ± 0.55	2.8	6.34 ± 0.52	6.02 ± 0.51	-5.0	0.105
IL-6 [pg/ml]	2.68 ± 0.20	2.67 ± 0.30	-0.3	2.83 ± 0.22	2.55 ± 0.36	-10.1	2.43 ± 0.40	2.88 ± 0.52	18.2	0.083
MCP-1 [pg/ml]	358 ± 40	347 ± 36	-3.1	327 ± 17	320 ± 20	-2.0	410 ± 103	392 ± 91	-4.5	0.946
CRP [mg/l]	0.86 ± 0.20	0.82 ± 0.19	-4.0	0.95 ± 0.29	0.93 ± 0.28	-2.2	0.71 ± 0.27	0.65 ± 0.21	-8.0	0.667
Data are shown as mean ± SEM, n = 29 unless otherwise indicated. For circulating markers, the average concentrations were calculated from four time point of data collection. For markers of substrate oxidation, the average levels were calculated from three time points of data collection. * p<0.05 for HC/HF vs. HF/HC diet (paired Student´s t-test or Wilcoxon test).
1 - P-value for the diet x subgroup interaction in repeated measures ANOVA analysis.
2 – n=27.





Figure 1. Whole-body and hepatic substrate oxidation in response to the HC/HF and the HF/HC diet. 
(A)	Study design. In the cross-over study, two four-week dietary intervention periods were separated by a washout phase. HC/HF diet, isocaloric carbohydrate-rich meals until 13.30 and isocaloric fat-rich meals between 16.30 and 22.00; HF/HC diet, reversed order of meal sequence. (B) Clinical investigation day. At 09.00 and 15.40 a standardized test meal – fat-rich or carbohydrate-rich – (grey bars) was provided according to participant´s previous intervention. Arrows indicate the collection of blood samples. (C) Energy expenditure, (D) respiratory quotient, (E) carbohydrate oxidation, and (F) lipid oxidation rates in the fasting state and 155 min after completion of each test meal (three time points in total) assessed by indirect calorimetry (n=27). (G) Beta-hydroxybutyrate concentrations in serum before and after completion of each test meal - at four time points in total (HC/HF diet - black circles, HF/HC diet - open circles, n=29). Arrows indicate test meals. Two-way repeated measure ANOVA was performed to determine the effect of diet, time and diet*time interaction. * p<0.05 - HC/HF diet vs. HF/HC diet at the same time of the day (paired Student´s t-test or Wilcoxon test). Data are shown as mean ± SEM. HC/HF, isocaloric carbohydrate-rich meals until 13.30 and fat-rich meals between 16.30 and 22.00; HF/HC, isocaloric fat-rich meals until 13.30 and carbohydrate-rich meals between 16.30 and 22.00; EE, energy expenditure; NC, nutritional counselling; RQ, respiratory quotient; V, visit; VCO2, volume carbon dioxide; VO2, volume oxygen. 

Figure 2. Blood lipids in response to the HC/HF and the HF/HC diet. 
Effects of the HC/HF diet (black circles) and the HF/HC diet (open circles) on pre- and postprandial concentrations of triglycerides (A), total cholesterol (B), HDL cholesterol (C) and LDL cholesterol (D). Arrows indicate test meals. Two-way repeated measure ANOVA was performed to determine the effect of diet, time and diet*time interaction. * p<0.05 - HC/HF diet vs. HF/HC diet at the same time of the day; # p<0.05 - afternoon vs. morning for preprandial (-5 min) or postprandial (180 min) samples for MTT-HC; § p<0.05 - afternoon vs. morning for preprandial (-5 min) or postprandial (180 min) samples for MTT-HF (all comparisons with paired Student´s t-test or Wilcoxon test). Data are shown as mean ± SEM, n=29. HC/HF, isocaloric carbohydrate-rich meals until 13.30 and fat-rich meals between 16.30 and 22.00;  HDL, high density lipoprotein; HF/HC, isocaloric fat-rich meals until 13.30 and carbohydrate-rich meals between 16.30 and 22.00; LDL, low-density lipoprotein.  

Figure 3. Adipokines and inflammatory markers in response to the HC/HF and the HF/HC diet. 
Effects of the HC/HF diet (black circles) and the HF/HC diet (open circles) on pre- and postprandial concentrations of leptin (A), visfatin (B), adiponectin (C), IL-6 (D), MCP-1 (E), CRP (F). Arrows indicate test meals. Two-way repeated measure ANOVA was performed to determine the effect of diet, time and diet*time interaction. * p<0.05 - HC/HF diet vs. HF/HC diet at the same time of the day; # p<0.05 - afternoon vs. morning for preprandial (-5 min) or postprandial (180 min) samples for MTT-HC; § p<0.05 - afternoon vs. morning for preprandial (-5 min) or postprandial (180 min) samples for MTT-HF (all comparisons with paired Student´s t-test or Wilcoxon test). Data are shown as mean ± SEM, n=29. CRP, C-reactive protein; HC/HF, isocaloric carbohydrate-rich meals until 13.30 and fat-rich meals between 16.30 and 22.00; HF/HC, isocaloric fat-rich meals until 13.30 and carbohydrate-rich meals between 16.30 and 22.00; IL-6, interleukin 6; MCP-1, monocyte chemoattractant protein-1. 



